carmustine
Megjelenés
| Names | |
|---|---|
| IUPAC name
1,3-Bis(2-chloroethyl)-1-nitrosourea[1] | |
| Other names
N,N'-Bis(2-chloroethyl)-N-nitrosourea, bis-chloroethylnitrosourea, BCNU | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| EC Number |
|
| KEGG | |
| MeSH | Carmustine |
PubChem CID |
|
| RTECS number |
|
| UNII | |
| UN number | 2811 |
| |
| |
| Properties | |
| C5H9Cl2N3O2 | |
| Molar mass | 214.046 g·mol−1 |
| Appearance | Orange crystals |
| Odor | Odourless |
| Melting point | 30 °C (86 °F; 303 K) |
| log P | 1.375 |
| Acidity (pKa) | 10.194 |
| Basicity (pKb) | 3.803 |
| Pharmacology | |
| L01AD01 (WHO) | |
| |
| License data | |
| Legal status | |
| Hazards | |
| GHS labelling: | |
| Sablon:gHS skull and crossbones Sablon:gHS health hazard | |
| Danger | |
| H300, H350, H360 | |
| P301+P310, P308+P313 | |
| Lethal dose or concentration (LD, LC): | |
LD50 (median dose) |
20 mg kg−1 (oral, rat) |
| Related compounds | |
Related ureas |
1,3-Dimethylurea |
Related compounds |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
| Clinical data | |
|---|---|
| Trade names | BiCNU, Gliadel |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682060 |
| License data |
|
| Drug class | Antineoplastic agents |
| Chemical and physical data | |
| Molar mass | 0 g·mol−1 |
Főnév
carmustine (tsz. carmustines)
- carmustine - Szótár.net (en-hu)
- carmustine - Sztaki (en-hu)
- carmustine - Merriam–Webster
- carmustine - Cambridge
- carmustine - WordNet
- carmustine - Яндекс (en-ru)
- carmustine - Google (en-hu)
- carmustine - Wikidata
- carmustine - Wikipédia (angol)
- ↑ Sablon:PubChem
- ↑ Carmustine 100mg Powder and solvent for Solution for Infusion - Summary of Product Characteristics (SmPC). (emc) , 2020. március 24.
- ↑ Gliadel 7.7mg Implant - Summary of Product Characteristics (SmPC). (emc) , 2020. június 15.
- ↑ Bicnu- carmustine kit. DailyMed
- ↑ Gliadel- carmustine wafer. DailyMed

